Trials / Unknown
UnknownNCT04343547
Study to Evaluate Drug-Drug Interaction of DWP16001 in Combination With DWC202001 and DWC202002 in Healthy Male Adults
A Randomized, Open Label, Single/Multiple Dose, Crossover Study to Evaluate Drug-Drug Interaction of DWP16001 in Combination With DWC202001 and DWC202002 in Healthy Male Adults
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 34 (estimated)
- Sponsor
- Daewoong Pharmaceutical Co. LTD. · Industry
- Sex
- Male
- Age
- 19 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate drug-drug interaction by comparing the pharmacokinetics (PK)/pharmacodynamics (PD), safety, and tolerability of single/multiple doses of DWP16001 , DWC202001 and DWC202002 alone or in combination in healthy male adults.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DWP16001 | Tablets, Oral, once daily single dose |
| DRUG | DWC202001+DWC202002 | Tablets, Oral, multiple doses of DWC202001 and DWC202002 in combination |
| DRUG | DWP16001+DWC202001+DWC202002 | Tablets, Oral, DWP16001 , DWC202001 and DWC202002 in combination |
Timeline
- Start date
- 2020-04-01
- Primary completion
- 2020-07-01
- Completion
- 2020-07-01
- First posted
- 2020-04-13
- Last updated
- 2020-04-27
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04343547. Inclusion in this directory is not an endorsement.